Welcome to LookChem.com Sign In|Join Free
  • or
2-(oxan-2-yloxy)isoindole-1,3-dione is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

6584-60-7

Post Buying Request

6584-60-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

6584-60-7 Usage

Derivative of isoindole-1,3-dione

2-(oxan-2-yloxy)isoindole-1,3-dione is derived from the parent compound isoindole-1,3-dione, which is a structurally similar compound.

Pharmaceutical industry applications

2-(oxan-2-yloxy)isoindole-1,3-dione has potential applications in the pharmaceutical industry due to its therapeutic properties.

Anti-inflammatory properties

The compound may exhibit anti-inflammatory properties, which could be useful in treating various inflammatory conditions.

Antioxidant properties

2-(oxan-2-yloxy)isoindole-1,3-dione may have antioxidant properties, which could help protect cells from damage caused by free radicals.

Anticancer properties

The compound may also possess anticancer properties, making it a potential candidate for cancer treatment and research.

Enhanced solubility and bioavailability

The addition of the oxan-2-yloxy group may improve the compound's solubility and bioavailability, making it more suitable for drug development.

Fluorescence properties

Isoindole-1,3-dione derivatives, including 2-(oxan-2-yloxy)isoindole-1,3-dione, are known for their fluorescence properties, which may have applications in chemical and biological imaging.

Therapeutic and technological significance

2-(oxan-2-yloxy)isoindole-1,3-dione is a compound with potential therapeutic and technological importance, making it a promising candidate for further research and development.

Check Digit Verification of cas no

The CAS Registry Mumber 6584-60-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,5,8 and 4 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 6584-60:
(6*6)+(5*5)+(4*8)+(3*4)+(2*6)+(1*0)=117
117 % 10 = 7
So 6584-60-7 is a valid CAS Registry Number.
InChI:InChI=1/C13H13NO4/c15-12-9-5-1-2-6-10(9)13(16)14(12)18-11-7-3-4-8-17-11/h1-2,5-6,11H,3-4,7-8H2

6584-60-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(oxan-2-yloxy)isoindole-1,3-dione

1.2 Other means of identification

Product number -
Other names tetrahydropyranyl ether of N-hydroxyphthalimide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:6584-60-7 SDS

6584-60-7Downstream Products

6584-60-7Relevant academic research and scientific papers

New hydroxamic acid derivatives of fluoroquinolones: Synthesis and evaluation of antibacterial and anticancer properties

Rajulu, Gavara Govinda,Naik, Halehatty Seephya Bhojya,Viswanadhan, Abhilash,Thiruvengadam, Jayaraman,Rajesh, Kondodiyil,Ganesh, Sambasivam,Jagadheshan, Hiriyan,Kesavan, Poonimangadu Koppolu

, p. 168 - 175 (2014)

A series of new hydroxamic acid derivatives (6a-f) at C-3 position of fluoroquinolones were designed and synthesized through multistep synthesis. The design concept involved replacement of the 3-carboxylic acid in fluoquinolones with hydroxamic acid as an acid mimicking group. The synthetic work employed in this work provides a good example for the synthesis of pure hydroxamic acid based fluoroquinolones. The synthesized compounds were characterized by 1H-NMR, electrospray ionization (ESI)-MS and IR. The new compounds were tested for their in vitro antimicrobial and anti-proliferative activity. Out of the six derivatives, compound 6e exhibited moderate antibacterial activity by inhibiting the growth of Escherichia coli and Klebsiella pneumoniae (MIC: 4.00-8.00 μg/mL). Compounds 6b and 6f displayed good growth inhibition against A549 Lung adenocarcinoma and HCT-116 Colon carcinoma cell lines.

Photo-induced radical borylation of hemiacetals via C–C bond cleavage

Liu, Qianyi,Zhang, Jianning,Zhang, Lei,Mo, Fanyang

supporting information, (2021/01/05)

In this study, we reported a photo-induced radical borylation of hemiacetal derivatives via C–C bond cleavage. This transformation can be realized under mild conditions with simple reaction settings and irradiation of visible light. A series of substrates, including both cyclic and linear hemiacetal derivatives, were effectively transformed to the borylation product in moderate to good yields. Finally, the mechanism was studied in detail by DFT calculations, suggesting insight of the radical borylation process.

Photoinduced Fragmentation Borylation of Cyclic Alcohols and Hemiacetals

Aggarwal, Varinder K.,Madhavachary, Rudrakshula,Noble, Adam,Shu, Chao

supporting information, p. 7213 - 7218 (2020/10/12)

A visible-light photoinduced fragmentation borylation of O-phthalimido cycloalkanols with bis(catecholato)diboron is described. Structurally diverse keto and formyloxy alkyl boronic esters are shown to be conveniently prepared by radical-mediated ring opening of cyclic alcohols and hemiacetals, respectively. The reactions proceed under mild conditions in the absence of additives or photocatalysts, display excellent functional group tolerance, and are shown to allow cleavage of 4-, 5-, 6-, and 7-membered ring substrates. The mechanism proceeds via sequential homolytic N-O and C-C bond cleavages, the latter of which involves β-scission of an alkoxy radical, generating a carbonyl and an alkyl radical that is trapped by the diboron reagent. Spectroscopic studies suggest direct photoexcitation of either the phthalimide or diboron substrates with blue light can initiate a radical chain mechanism.

Ultrasound accelerated synthesis of: O-alkylated hydroximides under solvent- A nd metal-free conditions

Jiang, Hongmei,Tang, Xiaoyue,Liu, Sihan,Wang, Lian,Shen, Haicheng,Yang, Jiankui,Wang, Huixian,Gui, Qing-Wen

, p. 10223 - 10227 (2019/12/26)

A novel, sustainable, environmentally friendly, high substrate scope, efficient, solvent-free and metal catalyst-free method for the cross-dehydrogenative coupling (CDC) reaction between N-hydroxyphthalimide (NHPI) and benzyl/ether compounds is described. This coupling reaction proceeds through ultrasound acceleration. Compared to conventional heating conditions, the use of ultrasound techniques not only improves the reaction efficiency and enhances the reaction rate but also minimizes the side reactions.

Synthesis of α-oxygenated ketones and substituted catechols via the rearrangement of N-enoxy- and N-aryloxyphthalimides

Kroc, Michelle A.,Patil, Aditi,Carlos, Anthony,Ballantine, Josiah,Aguilar, Stephanie,Mo, Dong-Liang,Wang, Heng-Yen,Mueller, Daniel S.,Wink, Donald J.,Anderson, Laura L.

supporting information, p. 4125 - 4137 (2017/06/29)

A common approach to the synthesis of α-oxygenated carbonyl compounds and catechols is the treatment of a carbonyl compound or a phenol with an electrophilic oxygen source. As an alternative approach to these important structures, formal [3,3]-rearrangements of N-enoxyphthalimides, N-enoxyisoindolinones, and N-aryloxyphthalimides have been explored. When used in combination with an initial Chan-Lam coupling, these transformations facilitate the dioxygenation of alkenylboronic acids for the synthesis of α-oxygenated ketones and the dioxygenation of arylboronic acids for the synthesis of catechols. The rearrangements of N-enoxyisoindolinones have also been shown to be diastereoselective.

Copper nitrate-catalyzed oxidative coupling of unactivated C(sp3)-H bonds of ethers and alkanes with: N -hydroxyphthalimide: Synthesis of N -hydroxyimide esters

Xu, Xiaohe,Sun, Jian,Lin, Yuyan,Cheng, Jingya,Li, Pingping,Yan, Yiyan,Shuai, Qi,Xie, Yuanyuan

supporting information, p. 9875 - 9879 (2017/12/12)

A copper nitrate-catalyzed cross-dehydrogenative coupling reaction between N-hydroxyphthalimide (NHPI) and ethers/alkanes has been described. The reaction is accomplished smoothly by using simple and green molecular oxygen as the oxidant, providing an alternative for the efficient synthesis of N-alkoxyphthalimides. In addition, it was found that when tert-butyl ethers were used as substrates, unexpected N-hydroxyimide ester derivatives were obtained in moderate to excellent yields. To further understand this unusual transformation, control experiments were performed and a plausible mechanism was proposed.

Copper(II)-catalyzed cross dehydrogenative coupling reaction of N-hydroxyphthalimide with alkanes and ethers via unactivated C(sp3)-H activation at room temperature

Guo, Zhicheng,Jin, Can,Zhou, Jiadi,Su, Weike

, p. 79016 - 79019 (2016/09/09)

A copper(ii)-catalyzed cross dehydrogenative coupling reaction between N-hydroxyphthalimide and unactivated C(sp3)-H bonds of alkanes and ethers using Selectfluor as an oxidant is described. This efficient reaction system shows mild conditions and a broad substrate scope for the generation of O-substituted N-hydroxyphthalimide derivatives.

Oseltamivir hydroxamate and acyl sulfonamide derivatives as influenza neuraminidase inhibitors

Hong, Bei-Tao,Chen, Chun-Lin,Fang, Jim-Min,Tsai, Keng-Chang,Wang, Shi-Yun,Huang, Wen-I,Cheng, Yih-Shyun E.,Wong, Chi-Huey

supporting information, p. 6647 - 6654 (2015/02/19)

Tamiflu, the ethyl ester form of oseltamivir carboxylic acid (OC), is the first orally available anti-influenza drug for the front-line therapeutic option. In this study, the OC-hydroxamates, OC-sulfonamides and their guanidino congeners (GOC)

HDAC INHIBITING DERIVATIVES OF CAMPTOTHECIN

-

Page/Page column 37-38, (2012/07/28)

The disclosure includes hydroxamic compounds of Formula I: (Formula I) wherein Z, L, R1, R2, and R3 are defined herein. Also disclosed is a method for treating a neoplastic disease or an immune disease with these compounds.

Hydroxamic acid-based bisubstrate analog inhibitors of Ras farnesyl protein transferase

Patel, Dinesh V.,Young, Marian G.,Robinson, Simon P.,Hunihan, Lisa,Dean, Brenda J.,Gordon, Eric M.

, p. 4197 - 4210 (2007/10/03)

The rational design, synthesis, and activity of novel, hydroxamic acid- based, collective bisubstrate analog inhibitors of farnesyl protein transferase (FPT) is described. This class of compounds differ structurally from the conventional FPT inhibitors by

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 6584-60-7